Stocks in Volatile Measures: Advanced Micro Devices (NASDAQ:AMD), Monster Digital (NASDAQ:MSDI)

Advanced Micro Devices, Inc. (NASDAQ:AMD) [Trend Analysis] moved up reacts as active mover, shares a gain remains unchanged to traded at $10.34 and the percentage gap between open changing to regular change was 0.39%. AMD delivers crimson relive drivers: yearly feature update for radeon gamers and professionals. This time last year we saw the launch of Radeon Crimson. This was AMD’s big attempt to state that a yearly cadence for software features was a good thing, and helped streamline the process for the number of initiatives that AMD participates in when it comes to GPUs.

This year the update is called ‘Crimson ReLive’, and features a number of updates such as integrating the professional aspect of Radeon Pro into the cadence, a push towards VR features, and additional elements to gamers/streamers and even screen recording for professional software. The firm’s current ratio calculated as 1.90 for the most recent quarter. The firm past twelve months price to sales ratio was 2.32. As far as the returns are concern, the return on equity was recorded as 232.40% and return on investment was -27.10% while its return on asset stayed at -16.90%. The firm has total debt to equity ratio measured as 4.24.

Monster Digital, Inc. (NASDAQ:MSDI) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it -1.17% to close at $1.52 with the total traded volume of 34121 shares. Monster Digital, Inc. (NASDAQ:MSDI) declared that exhibition of its new Virtual Reality (VR) and 360 action sports cameras to travel retailers at the 14th Annual Hudson Group Vendor Show in Las Vegas on December 5, 2016.

After attending the show with members of the Monster Digital sales team, Jonathan Clark, Interim President, commented, “The Hudson Group Vendor Show was a great opportunity to showcase our VR camera at this well attended, high-profile event. We look forward to following up on the connections we made while presenting our exciting product line to the travel retail market place.” Its price to sales ratio ended at 2.51.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *